Bioventus

Bioventus EV/FCF

The EV/FCF (Enterprise Value to Free Cash Flow) of Bioventus (BVS) as of Oct 18, 2026 is 13.04. In the previous year, EV/FCF (Enterprise Value to Free Cash Flow) was 26.17 — a change of -50.16% (lower).

EV/FCF

13.04

YoY

-50.16%

Last updated:

EV/FCF (Enterprise Value to Free Cash Flow) of Bioventus is 2025 13.04 . EV/FCF (Enterprise Value to Free Cash Flow) of Bioventus was 2024 26.17 . It decreases by -50.16% lower compared to the previous year.

The Bioventus EV/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/FCF
Date
EV/FCF
Jan 1, 2018
21.38 USD
Jan 1, 2019
25.27 USD
Jan 1, 2020
15.37 USD
Jan 1, 2021
63.90 USD
Jan 1, 2022
-71.42 USD
Jan 1, 2023
131.98 USD
Jan 1, 2024
26.17 USD
Jan 1, 2025
13.04 USD
The Bioventus EV/FCF history
YEAREV/FCFYoY
13.04-50.16%
26.17-80.17%
131.98-284.80%
-71.42-211.76%
63.90+315.66%
15.37-39.16%
25.27+18.19%
21.38-71.99%
76.32-152.00%
-146.77—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Bioventus Stock analysis

What does Bioventus do? Bioventus Inc. is a company specializing in the development, manufacture, and marketing of biological solutions for patients with bone and joint problems. It was founded in 2012 by a group of orthopedic specialists and venture capital investors. The company is headquartered in Durham, North Carolina, USA and is a leading provider of clinically proven biological solutions for patients with orthopedic conditions. Bioventus works closely with orthopedic surgeons and hospitals to ensure its products meet the needs of patients. Its portfolio includes orthobiologics, bone healing, and surgical products. Some of its notable products include Gel-One® Cross-Linked Hyaluronic Acid for osteoarthritis treatment, EXOGEN® Ultrasound Bone Healing System for improving bone healing, and BONESUPPORT® Cerament® bone void filler for bone regeneration. Bioventus is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Bioventus stock

EV/FCF (Enterprise Value to Free Cash Flow) of Bioventus is 13.04 in 2025.

EV/FCF (Enterprise Value to Free Cash Flow) of Bioventus changed from 26.17 to 13.04, representing a -50.16% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EV/FCF (Enterprise Value to Free Cash Flow) Bioventus since 2006 – with annual values, charts, and detailed analysis.

The EV/FCF ratio measures the enterprise value relative to free cash flow. It captures the true cash-generating ability of a business.

To evaluate EV/FCF (Enterprise Value to Free Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/FCF (Enterprise Value to Free Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/FCF (Enterprise Value to Free Cash Flow)'s Bioventus with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Bioventus

All Key Metrics — Bioventus